[
    [
        {
            "time": "",
            "original_text": "港股多个板块遇“劫日”，新冠特效药传闻重创医药股，龙头复星医药跌近20%，为何多个板块成惊弓之鸟",
            "features": {
                "keywords": [
                    "港股",
                    "板块",
                    "劫日",
                    "新冠特效药",
                    "传闻",
                    "医药股",
                    "复星医药",
                    "下跌"
                ],
                "sentiment_score": -0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "港股多个板块遇“劫日”，新冠特效药传闻重创医药股，龙头复星医药跌近20%，为何多个板块成惊弓之鸟",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 9,
                "Duration": 7,
                "Entity_Density": 6,
                "Market_Scope": 8,
                "Time_Proximity": 9,
                "Headline_Structure": 10,
                "Source_Recency": 9
            }
        }
    ]
]